For individuals considering pregnancy, or who are pregnant, how should IBD treatments be modified to ensure that the mother’s disease is well treated and yet are safe for the developing fetus?
Optimal management of IBD before and during pregnancy is essential to achieving favourable maternal and neonatal outcomes and should be directed by a specialist in IBD.
Nguyen GC, Seow CH, Maxwell C, et al. IBD in Pregnancy Consensus Group; Canadian Association of Gastroenterology. The Toronto Consensus Statements for the Management of Inflammatory Bowel Disease in Pregnancy. Gastroenterology. 2016;150(3):734–57. http://www.ncbi.nlm.nih.gov/pubmed/26688268
A systematic literature search identified studies on the management of IBD during pregnancy. The quality of their evidence was assessed using the Grading of Recommendation Assessment, Development and Evaluation (GRADE) approach. The aim of the recommendations was to optimize IBD therapy for flare prevention during pregnancy.
Optimal management of IBD before and during pregnancy is essential to achieve favorable maternal and neonatal outcomes. Specifically:
Study Design: Expert, consensus-based opinions
Level of Evidence: 1a (Oxford Levels of Evidence)
The summary and conclusion in this issue of E-mentoring in IBD pertains to the manuscript(s) being reviewed, and should be considered in the context of what is already known surrounding the topic and incorporated into practice as deemed appropriate by the individual learner.